WardellW. M.HassarM.AnavekarS. N.LasagnaL.: Rate of Development of New Drugs in the U.S., 1963–1975, Clin. Pharmacol. Ther. 24:133–145, 1978.
2.
MarchandC. R.: Physician Attitudes Toward Sources of Drug Information, Drug Inf. J.11:225–226, 1977.
3.
MeadowsR. J.: Drug Information: The Pharmaceutical Manufacturer's Viewpoint and Involvement, Drug Inf. J.11:221–224, 1977.
4.
EckelR. M.: Pharmacy Sources of Drug Information, Drug Inf. J.13:15–20, 1979.
5.
StrossJ. K.HarlanW. R.: The Dissemination of New Medical Information, JAMA241:2622–2624, 1979.
6.
StinsonE. R.MuellerD. A.: Survey of Health Professionals'Information Habits and Needs, JAMA243:140–143, 1980.
7.
HermanC. M.RodauskasC. A.: Communicating Drug Information to Physicians, J. Med. Educ. 51:189–196, 1976.
8.
ChristensenD. B.WertheimerA. I.: Sources of Information and Influence of New Drug Prescribing Among Physicians in an HMO, Soc. Sci. Med.13A:313–322, 1979.
9.
RelmanA. S.: The Sulindac Story: What is Medical News?, N. Engl. J. Med.300:733–734, 1979.
10.
KleinmanG.: The Physician's Drug Adoption Process Re: Product Risk, Med. Mark. Media14:46–50, 1979.
